Quantum Immunologics, Inc. (QI)
was formed for the sole purpose of developing, implementing and distributing new advanced levels of designer therapeutic treatments and diagnostic tools including all of the patents and intellectual properties exclusively licensed from the University of South Alabama (USA) as well as our internally developed QI provisional patents. QI’s goal is to foster the development and support for these and other technologies that are complementary to its current portfolio of patented intellectual properties focused on immune diseases and disorders.
